The prediction of response to galantamine treatment in patients with mild to moderate Alzheimer's disease.
about
Clinicians' prescription preferences for treating patients with Alzheimer's disease in Shanghai.Long-Term Efficacy of Galantamine in Alzheimer's Disease: The Okayama Galantamine Study (OGS).Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine.Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors
P2860
The prediction of response to galantamine treatment in patients with mild to moderate Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The prediction of response to ...... moderate Alzheimer's disease.
@en
The prediction of response to ...... moderate Alzheimer's disease.
@nl
type
label
The prediction of response to ...... moderate Alzheimer's disease.
@en
The prediction of response to ...... moderate Alzheimer's disease.
@nl
prefLabel
The prediction of response to ...... moderate Alzheimer's disease.
@en
The prediction of response to ...... moderate Alzheimer's disease.
@nl
P2093
P2860
P1476
The prediction of response to ...... moderate Alzheimer's disease.
@en
P2093
Masayoshi Takahashi
Nami Sugiyama
Takashi Ohnishi
Takayuki Saito
Takumi Kobayashi
Yojiro Sakiyama
Yuichi Okuri
Yuji Kimura
P2860
P304
P356
10.2174/15672050113106660167
P577
2014-02-01T00:00:00Z